New GAO Reports: Brand-Name Prescription Drug Pricing, Corporate Crime, 2009 Tax Filing Season
Brand-Name Prescription Drug Pricing: Lack of Therapeutically Equivalent Drugs and Limited Competition May Contribute to Extraordinary Price Increases, GAO-10-201, December 22, 2009 Corporate Crime: DOJ Has Taken Steps to Better Track Its Use of Deferred and Non-Prosecution Agreements, but Should Evaluate Effectiveness, GAO-10-110, December 18, 2009 2009 Tax Filing Season: IRS Met Many 2009 Goals, …